CAMMED THERAPEUTICS LTD.
Significant control: Ahmet Can Berkyurek (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Cammed Therapeutics Ltd.: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Cammed Therapeutics Ltd. sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
CAMMED THERAPEUTICS LTD. is an active private limited company (company number 14592661) incorporated on 15 January 2023, registered in Ely. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 31 January 2025, with 2 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public.
There are 196 companies in research and experimental development on biotechnology in Cambridge with filed accounts; the median reports net assets of £15k and is 7 years old.
Ownership and control
- Dr. Ahmet Can Berkyurek
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
- Dr. Andreas Wilhelm Claas
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 15 January 20233 yrs ago
- Next accounts due
- 31 October 2026in 6 days
- Confirmation statement due
- 29 January 2027in 96 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 January 2025 | — | — | — | £688 | — | — | 2 |
| 31 January 2024 | — | — | — | £0 | — | — | 2 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
Filing and accounts signals
- Current assets at least 1.5× creditors within one yearCurrent ratio 142.76
- Incorporated two to five years agoIncorporated 15 January 2023
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Confirmation statement duein 96 days
- Next accounts duein 6 days
- Accounts period end
- Accounts period end
- Incorporated
Similar companies in Cambridge
- BIOTRYP THERAPEUTICS LTDCambridge · inc. Jan 2023
- GENE WEAVER LTDHelions Bumpstead · inc. Dec 2022
- AAB RESEARCH LTDCambridge · inc. Dec 2022
- BRAVELYCULTURED LTDCambridge · inc. Dec 2022
- ENSOCELL LTDCambridge · inc. Mar 2023
- CYTEK BIOSCIENCES LTDEly · inc. Mar 2023
All companies incorporated on 15 January 2023 · in Jan 2023.
Reminders for CAMMED THERAPEUTICS LTD.
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.